Patent · US Active

Chimeric adenoviral vectors

US8222224B2 · kind B2 · utility

1Cited by
3References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 12, 2010
Grant dateJul 17, 2012
Priority date
Expiry dateNov 12, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides chimeric adenoviral vectors and methods for using the vectors to elicit an immune response to an antigen of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.